MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Smell and taste in cervical dystonia: a contribution to understand dystonia pathophysiology.

    T. Herr, T. Hummel, M. Vollmer, C. Willert, B. Lehnert, M. Kronenbürger (Greifswald, Germany)

    Objective: To contribute to the better understanding of the pathophysiology of cervical dystonia (CD) we systematically assessed olfactory and gustatory functioning in CD subjects and…
  • 2019 International Congress

    A novel heterozygous ANO3 mutation responsible for myoclonus-dystonia

    C. Laurencin, E. Broussolle, T. Danaila, M. Anheim, J. Chelly, S. Thobois (Lyon, France)

    Objective: We present a family carrying ANO3 mutation and exhibiting a myoclonus-dystonia and tremor phenotype. Background: Mutations of Anoctamine 3 gene (ANO3) are a rare…
  • 2019 International Congress

    Depression and anxiety in cervical dystonia

    M. Munteanu (Bucharest, Romania)

    Objective: We had proposed to evaluate appearance of anxiety and depression in patients with cervical dystonia(CD) and influence of disease on the quality of life.…
  • 2019 International Congress

    Unusual expression of fragile X premutation in a female patient: clinical and tractographic description

    V. Ros-Castelló, E. Natera-Villalba, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, S. Fanjul, J. López-Sendón, A. Alonso-Cánovas, JC. Martínez-Castrillo, J. álvarez-Linera, I. Pareés (Madrid, Spain)

    Objective: To present a case of dystonic head tremor in a female FMR1 premutation carrier. Background: Fragile X-associated tremor ataxia syndrome (FXTAS) is the main…
  • 2019 International Congress

    The Dutch Yips Study

    E. van Wensen, HJ. Vd Zaag, BP. Vd Warrenburg (Apeldoorn, Netherlands)

    Objective: To investigate the prevalence of the Yips in a well-defined group of golfers and to determine potential risk factors. Background: The Yips is a…
  • 2019 International Congress

    Goal setting for botulinum toxin injections: Impact of the Upper Limb International Spasticity (ULIS) programme

    K. Fheodoroff, S. Ashford, J. Jacinto, A. Brashear, P. Maisonobe, A. Lysandropoulos, L. Turner-Stokes (Hermagor, Austria)

    Objective: The Upper Limb International Spasticity (ULIS) programme is a series of observational cohort studies across >30 countries. This analysis explores changes in goal setting…
  • 2019 International Congress

    Intact visuomotor forward models in adults with Tourette Syndrome

    A. Djodari-Irani, L. Kurvits, T. Mainka, A. Kühn, C. Ganos, F. Ostendorf (Berlin, Germany)

    Objective: To assess the integrity of forward model-driven predictions in a visuomotor task in adults with Tourette syndrome (TS). Background: Tics, such as those encountered…
  • 2019 International Congress

    Characteristics of patients with essential tremor evaluated for deep brain stimulation surgery at a tertiary center

    L. Deuel, J. Feuerstein, B. Berman, B. Hoyt, D. Kern (Aurora, CO, USA)

    Objective: Characterize patients with essential tremor (ET) referred to a tertiary center for deep brain stimulation (DBS), including reasons for not proceeding with surgery. Background:…
  • 2019 International Congress

    Resting-State fMRI in Essential Tremor after MRgFUS treatment

    C. Kindler, V. Purrer, N. Upadhyay, V. Keil, V. Borger, C. Pieper, L. Scheef, H. Boecker, U. Wuellner (Bonn, Germany)

    Objective: Identify network alterations in essential tremor (ET) after magnetic resonance–guided focused ultrasound (MRgFUS) treatment using independent component analysis (ICA). Background: MRgFUS has been approved…
  • 2019 International Congress

    Botulinum toxin injections reduce the symptoms of dystonic tremor and improve sensorimotor function for hand dexterity

    L. Rocchi, A. Latorre, G. Paparella, E. Menozzi, L. Peppoloni, F. Valero-Cuevas, C. Cordivari, K. Bhatia, J. Rothwell (London, United Kingdom)

    Objective: To assess improvement in hand function following therapy with botulinum toxin in patients with dystonic tremor (DT). Background: Treatment of dystonic tremor (DT) with…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley